Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,714.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 6.00 (0.35%)
Market Cap: £504.80m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Post Close Trading Update

13 Oct 2021 07:00

RNS Number : 8651O
Avon Protection PLC
13 October 2021
 

13 October 2021

Avon Protection plc

Post Close Trading Update

 

Avon Protection plc ("Avon" or the "Group") today provides the following post close trading update for its financial year ended 30 September 2021 ("FY21").

 

Trading update

Avon has continued to see good commercial momentum in the second half of FY21, with order intake for the year of c.$280 million. This represents total year-on-year order growth of 34% and growth of 15% excluding Team Wendy. As a result, the Group has carried a strong closing order book of $141 million into the new financial year ("FY22"), up 39% on 30 September 2020. This momentum underpins confidence in the Group's growth expectations for FY22.

 

The Group expects to report revenue of $250 million for FY21 (2020: $213.6 million), which is within the range indicated in our trading update of 13 August 2021. This includes a Team Wendy contribution of $41 million from the first 11 months of ownership, in line with expectations at the time of acquisition.

 

As expected, we have seen revenue growth in our First Responder business and Military respiratory portfolio, offset by declines in Military ballistic revenue due to the previously announced delays. Overall, Military revenue is expected to decline by 3% to $149 million with respiratory revenue growth of 10% being offset by a 31% decline in Military ballistic revenues. First Responder revenues are expected to have increased by 2% to $61 million, against a strong comparator in 2020, driven by very encouraging growth in our ballistic protection portfolio.

 

Trading profitability in the remainder of FY21 was in line with the expectations set out in the August trading update. The Group will however recognise one-off, non-cash, ballistic protection inventory adjustments, which are expected to reduce the reported adjusted EBITDA margin for FY21 to between 15% and 16%.

 

Cash conversion has come through more strongly than anticipated at the time of the August trading update. As a result, we expect FY21 reported cash conversion of c.80% and net debt before lease liabilities of $27 million at 30 September 2021.

 

Commenting, Paul McDonald, Chief Executive Officer, said:

"We have made considerable commercial progress over the last 12 months in continuing to build a broader portfolio of contracts, increasing our pipeline of opportunities and making record levels of investment in the business.

 

We carry significant commercial momentum into FY22, which will also benefit from a strong ramp-up in body armor, as well as the strengthened senior management, processes and infrastructure we have put in place over the past year whilst navigating the ongoing disruption related to Covid through our supply chains.

 

We remain well set for growth in FY22 and beyond and are as confident as ever about the medium-term prospects of Avon Protection. This is underpinned by a strong order book, a growing and visible contract pipeline and our global market leading positions in respiratory and ballistic protection."

 

Notice of Results

The Group will release its results for the year ended 30 September 2021 on 23 November 2021.

 

For further enquiries, please contact:

 

Avon Protection plc

Paul McDonald, Chief Executive Officer

01225 896 848

Nick Keveth, Chief Financial Officer

Rachel Stevens, Director of Investor Relations

MHP Communications

Andrew Jaques

0203 128 8570

Charlie Barker

avonprotection@mhpc.com

Pete Lambie

 

Legal Entity Identifier: 213800JM1AN62REBWA71

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

Note to editors: 

Avon Protection plc is listed on the London Stock Exchange (LSE: AVON) and is an innovative technology group, which designs and produces life critical personal protection systems to maximise the performance and capabilities of its customers, with leading positions in the respiratory and ballistic protection markets for the world's militaries and first responders.

For further information, please visit our website www.avon-protection-plc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFETIDLFLIL
Date   Source Headline
13th Nov 200712:30 pmRNSTotal Voting Rights
30th Oct 20077:01 amRNSNotice of Results
17th Oct 20073:27 pmRNSHolding(s) in Company
17th Oct 20077:00 amRNSViking Z Seven Approval
8th Oct 20071:33 pmRNSUK Mixing Operation
5th Oct 20077:00 amRNSRe: US JSGPM program
1st Oct 20075:31 pmRNSTotal Voting Rights
27th Sep 20077:01 amRNSAppointments
14th Sep 20077:00 amRNSMoU for Turkish Supply
3rd Sep 200710:30 amRNSTotal Voting Rights
21st Aug 20071:39 pmRNSHolding(s) in Company
3rd Aug 200710:04 amRNSHolding(s) in Company
1st Aug 20072:06 pmRNSTotal Voting Rights
29th Jun 200711:49 amRNSTotal Voting Rights
19th Jun 20077:01 amRNSShare Ownership Trust
18th Jun 20071:42 pmRNSHolding(s) in Company
13th Jun 20074:09 pmRNSShare Ownership Trust
1st Jun 200710:02 amRNSTotal Voting Rights
31st May 20077:02 amRNSInterim Report
17th May 20077:01 amRNSInterim Results
17th May 20077:01 amRNSBoard Appointment
1st May 20079:42 amRNSTotal Voting Rights
30th Apr 20074:36 pmRNSNotice of Results
25th Apr 20079:29 amRNSBlocklisting Interim Review
5th Apr 20074:15 pmRNSHolding(s) in Company
4th Apr 20076:03 pmRNSHolding(s) in Company
2nd Apr 20077:02 amRNSTrading Update
30th Mar 20072:17 pmRNSHolding(s) in Company
16th Mar 200710:10 amRNSHolding(s) in Company
13th Mar 20073:26 pmRNSHolding(s) in Company
9th Mar 200712:59 pmRNSHolding(s) in Company - Amend
8th Mar 20072:45 pmRNSHolding(s) in Company
1st Mar 20079:08 amRNSTotal Voting Rights
6th Feb 200712:41 pmRNSManagement Change
6th Feb 20079:48 amRNSAdditional Listing
1st Feb 20072:41 pmRNSTotal Voting Rights
30th Jan 20071:03 pmRNSHolding(s) in Company
25th Jan 200712:30 pmRNSAnnual General Meeting
25th Jan 20077:01 amRNSAGM Statement
19th Jan 200711:29 amRNSHolding(s) in Company
18th Jan 200711:46 amRNSTotal Voting Rights
12th Jan 200710:00 amRNSAnnual Information Update
5th Jan 200712:51 pmRNSDirector/PDMR Shareholding
3rd Jan 20074:20 pmRNSHolding(s) in Company
22nd Dec 20068:31 amRNSAnnual Report and Accounts
20th Dec 20063:05 pmRNSDirector/PDMR Shareholding
19th Dec 20062:54 pmRNSHolding(s) in Company
14th Dec 200610:55 amRNSDirector/PDMR Shareholding
14th Dec 200610:05 amRNSDirector/PDMR Shareholding
14th Dec 20067:01 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.